Decision-Making Training and Consulting at Gilead Sciences
Partnered with senior leadership across Gilead Sciences to scale enterprise decision-making capability through the Decisions@Gilead framework. Assisted in designing and implementing the 101, 201, and 301 learning programs delivered through live, virtual, and in-person formats to more than 4,000 employees across Regulatory, Safety, Quality, Medical Affairs, Development, Research, Vendor Outsourcing, and commercial leadership teams. Strengthened organizational effectiveness by improving how leaders and team members assess risk, align stakeholders, and execute high-stakes decisions.
Highlights of the engagement included:
Designed and operationalized a tiered enterprise learning strategy aligned to leadership level, function, and decision complexity
Delivered scalable programs for 4,000+ employees across global business units and leadership populations
Advised executive stakeholders on adoption strategy, governance alignment, and change management to embed Decisions@Gilead Sciences into the organization
Led targeted sessions for Executive Leadership Teams, General Managers, and senior functional leaders to improve strategic, portfolio, and governance decisions
Built advanced 301 programs for Virology, Inflammation, and Oncology teams, navigating complex investment and prioritization decisions
Standardized decision-making language and practices around DAI, risk continuum thinking, and private collection concepts
Additional responsibilities included:
Assisted in creating custom simulations, business cases, and role-based exercises tied to real organizational challenges
Facilitated team alignment workshops clarifying roles, decision rights, accountability, and operating norms
Coached leaders on stakeholder influence, message reframing, and post-decision execution discipline
Identified opportunities to streamline decision processes, reduce friction, and improve cross-functional speed and consistency
